rs11568188

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015166.4(MLC1):​c.1031A>G​(p.Asn344Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 1,480,250 control chromosomes in the GnomAD database, including 15,810 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. N344N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.099 ( 1081 hom., cov: 32)
Exomes 𝑓: 0.12 ( 14729 hom. )

Consequence

MLC1
NM_015166.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.631

Publications

19 publications found
Variant links:
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
  • megalencephalic leukoencephalopathy with subcortical cysts 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
  • megalencephalic leukoencephalopathy with subcortical cysts
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020861626).
BP6
Variant 22-50064062-T-C is Benign according to our data. Variant chr22-50064062-T-C is described in ClinVar as Benign. ClinVar VariationId is 21521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLC1NM_015166.4 linkc.1031A>G p.Asn344Ser missense_variant Exon 11 of 12 ENST00000311597.10 NP_055981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLC1ENST00000311597.10 linkc.1031A>G p.Asn344Ser missense_variant Exon 11 of 12 1 NM_015166.4 ENSP00000310375.6
MLC1ENST00000395876.6 linkc.1031A>G p.Asn344Ser missense_variant Exon 11 of 12 1 ENSP00000379216.2
MLC1ENST00000483836.1 linkn.388A>G non_coding_transcript_exon_variant Exon 4 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.0991
AC:
12277
AN:
123832
Hom.:
1081
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0575
Gnomad AMI
AF:
0.0916
Gnomad AMR
AF:
0.157
Gnomad ASJ
AF:
0.0612
Gnomad EAS
AF:
0.0826
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.0642
Gnomad MID
AF:
0.0985
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.123
GnomAD2 exomes
AF:
0.113
AC:
26164
AN:
232170
AF XY:
0.119
show subpopulations
Gnomad AFR exome
AF:
0.0551
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.0769
Gnomad EAS exome
AF:
0.0790
Gnomad FIN exome
AF:
0.0562
Gnomad NFE exome
AF:
0.114
Gnomad OTH exome
AF:
0.121
GnomAD4 exome
AF:
0.120
AC:
163080
AN:
1356324
Hom.:
14729
Cov.:
37
AF XY:
0.123
AC XY:
83100
AN XY:
675326
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0581
AC:
1879
AN:
32366
American (AMR)
AF:
0.113
AC:
4772
AN:
42184
Ashkenazi Jewish (ASJ)
AF:
0.0705
AC:
1787
AN:
25338
East Asian (EAS)
AF:
0.0892
AC:
3434
AN:
38504
South Asian (SAS)
AF:
0.196
AC:
15762
AN:
80562
European-Finnish (FIN)
AF:
0.0722
AC:
3334
AN:
46152
Middle Eastern (MID)
AF:
0.108
AC:
536
AN:
4944
European-Non Finnish (NFE)
AF:
0.121
AC:
124838
AN:
1029484
Other (OTH)
AF:
0.119
AC:
6738
AN:
56790
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.373
Heterozygous variant carriers
0
7459
14918
22377
29836
37295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4202
8404
12606
16808
21010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0991
AC:
12285
AN:
123926
Hom.:
1081
Cov.:
32
AF XY:
0.100
AC XY:
6042
AN XY:
60204
show subpopulations
African (AFR)
AF:
0.0578
AC:
1974
AN:
34150
American (AMR)
AF:
0.157
AC:
1898
AN:
12094
Ashkenazi Jewish (ASJ)
AF:
0.0612
AC:
183
AN:
2988
East Asian (EAS)
AF:
0.0829
AC:
345
AN:
4160
South Asian (SAS)
AF:
0.200
AC:
702
AN:
3516
European-Finnish (FIN)
AF:
0.0642
AC:
552
AN:
8594
Middle Eastern (MID)
AF:
0.0868
AC:
21
AN:
242
European-Non Finnish (NFE)
AF:
0.114
AC:
6335
AN:
55728
Other (OTH)
AF:
0.121
AC:
207
AN:
1712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
465
930
1396
1861
2326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.141
Hom.:
1499
Bravo
AF:
0.124
TwinsUK
AF:
0.131
AC:
487
ALSPAC
AF:
0.136
AC:
525
ESP6500AA
AF:
0.0663
AC:
292
ESP6500EA
AF:
0.127
AC:
1094
ExAC
AF:
0.0816
AC:
9819

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Megalencephalic leukoencephalopathy with subcortical cysts Benign:1
Nov 21, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
5.3
DANN
Benign
0.37
DEOGEN2
Benign
0.019
T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0092
N
LIST_S2
Benign
0.11
.;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.69
N;N
PhyloP100
0.63
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
0.55
N;N
REVEL
Benign
0.18
Sift
Benign
0.83
T;T
Sift4G
Benign
0.76
T;T
Polyphen
0.0
B;B
Vest4
0.039
MPC
0.20
ClinPred
0.00075
T
GERP RS
1.7
Varity_R
0.025
gMVP
0.075
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11568188; hg19: chr22-50502491; COSMIC: COSV61115728; API